Author | Country | VFX | Instrument | PCS | MCS | Comments | ||
---|---|---|---|---|---|---|---|---|
Without VFX | With VFX | Without VFX | With VFX | |||||
FRAVO study | Spain | Prevalent | SF12 | 45.3; 45.7 | 41.6; 40.2 | 45.6; 44.0 | 46.3; 45.5 | Scores for mild and moderate-severe VFX. |
Lai et al, 2010[34] | China | Prevalent | SF36 | 14.3 | 14.1; 12.7 | 27.8 | 27.7; 27.2 | Scores for morphometric and clinical VFX.* |
Van Schoor et al 2005[18] | Holland | Prevalent | SF12 | 50.0 | 49.5; 50.8; 42.1 | 55.8 | 55.6; 53.6; 55.0 | Scores for mild, moderate and severe VFX. |
Cockerill et al, 2004[27] | Europe | Prevalent Incident | SF12 | 43.7 | 41.2 (39.9) | 49.1 | 50.8 (47.2) | Scores for incident VFX in brackets. |
Hallberg et al, 2004[28] | Sweden | Incident | SF36 | 44.3 | 29.6 (34.2) | 51.3 | 45.8 (44.3) | Scores 2 years after the incident VFX in brackets. |
Falch et al, 2003[29] | Norway | Incident | SF36 | 46.2 | 31.7 | 46.0 | 46.2 | Referred to hospital for clinical VFX |
Adachi et al, 2001[23] | Canada | Prevalent | SF36 | 48 | 44 | 53 | 54 | Morphometric subclinical VFX. |
Tosteson et al, 2001[24] | USA | Prevalent | SF36 | 47.1 | 40.1 | 53.6 | 54.7 | 45% with clinical VFX. |
Naves Diaz et al, 2001[25] | Spain | Prevalent | SF36 | 50 | 47 | 50 | 48 | Population study |
Hall et al, 1999[26] | Australia | Prevalent | SF36 | 48 | 36 | 54 | 50 | Referred to hospital for clinical VFX |